Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis
Clinical trial NCT03252340 · COMPLETED
Trial details
- NCT number
- NCT03252340
- Sponsor
- EHL Bio Co., Ltd.
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2017-09-19
- Primary completion
- 2022-08-17
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.